Truumees Eeric, Duncan Ashley, Singh Devender, Geck Matthew J, Adindu Ebubechi, Stokes John K
Department of Spine and Scoliosis, The University of Texas Dell Medical School, Ascension Texas Spine and Scoliosis.
Department of Spine and Scoliosis, Ascension Texas Spine and Scoliosis, Austin.
Clin Spine Surg. 2025 Aug 1;38(7):E395-E399. doi: 10.1097/BSD.0000000000001750. Epub 2024 Nov 26.
STUDY DESIGN/SETTING: Retrospective cohort analysis.
To determine what factors are associated with high-risk daily morphine milligram equivalent (MME) totals in patients undergoing spinal decompression.
Daily dosages of ≥100 MME/d are associated with an almost 9-fold increased risk of overdose. Current general recommendations endorse the lowest effective dose and ≤50 MME/d.
Retrospective analysis was conducted on 260 patients who underwent spinal decompressive surgery. Average MME/d was calculated as the sum of qualifying inpatient MMEs administered divided by the sum of inpatient length of stay. Independent variables across demographic, clinical, and surgical domains were subject to comparative and logistic regression analysis.
Overall MME per day was 54.19 ± 39.37, with a range of 1.67-218.34 MME/d. Sixty-six patients were determined to have "high-risk MME." These patients were significantly younger (58.8 ± 13.1 vs 70.53 ± 11.5; P < 0.001) and reported higher preoperative pain visual analog scale (VAS; 4.8 ± 3 vs 2.8 ± 3.3; P = 0.0021) than the patients at low risk. In addition, high-risk patients had significantly higher body mass indexes (BMIs; P < 0.05) and received ketamine as part of anesthesia ( P < 0.05). Patients who consumed high-risk dosages of MMEs in the perioperative period were more likely to have been on opioids before surgery and to report higher pain scores at 4-6 week follow-ups ( P < 0.05). The final logistics regression model identified independent risk factors to be younger age, higher BMIs and preoperative VAS, and prior use of opioids and intraoperative ketamine.
Patients with high MME per day who underwent spinal decompression were significantly younger with higher BMIs and preoperative VAS with an increased incidence of preoperative opioid use and intraoperative ketamine. A closer look at interaction models revealed that a combination of high preoperative pain and intraoperative ketamine usage were at a significantly increased risk of higher MME consumption. Preoperative opioid risk education and mitigation strategies should be considered in patients with high MME risk, especially in younger patients already utilizing opioids before surgery.
研究设计/背景:回顾性队列分析。
确定在接受脊柱减压手术的患者中,哪些因素与每日高风险吗啡毫克当量(MME)总量相关。
每日剂量≥100 MME/d与过量用药风险增加近9倍相关。当前的一般建议支持使用最低有效剂量且≤50 MME/d。
对260例行脊柱减压手术的患者进行回顾性分析。平均每日MME通过将合格住院期间给予的MME总和除以住院总天数来计算。对人口统计学、临床和手术领域的自变量进行比较和逻辑回归分析。
每日总体MME为54.19±39.37,范围为1.67 - 218.34 MME/d。66例患者被确定为“高风险MME”。这些患者明显更年轻(58.8±13.1岁对70.53±11.5岁;P<0.001),且术前疼痛视觉模拟量表(VAS)评分更高(4.8±3对2.8±3.3;P = 0.0021),高于低风险患者。此外,高风险患者的体重指数(BMI)显著更高(P<0.05),且麻醉中使用了氯胺酮(P<0.05)。围手术期使用高风险剂量MME的患者术前更可能已在使用阿片类药物,且在4 - 6周随访时疼痛评分更高(P<0.05)。最终的逻辑回归模型确定独立危险因素为年龄较小、BMI较高、术前VAS评分较高、术前使用过阿片类药物以及术中使用氯胺酮。
接受脊柱减压手术且每日MME较高的患者明显更年轻,BMI较高,术前VAS评分较高,术前使用阿片类药物和术中使用氯胺酮的发生率增加。对交互模型的进一步研究表明,术前疼痛程度高和术中使用氯胺酮相结合会使MME消耗量更高的风险显著增加。对于高MME风险患者,尤其是术前已在使用阿片类药物的年轻患者,应考虑进行术前阿片类药物风险教育和缓解策略。